AI summary · may contain errors
Semaglutide lowered time to first major kidney composite events versus placebo in pooled SELECT, FLOW, and SOUL participants (N=30 787; HR 0·84, 95% CI 0·77–0·91).
- Open access
- 5 cites
Moving in The Lancet Diabetes & Endocrinology.
Rebuilt
AI summary · may contain errors
Semaglutide lowered time to first major kidney composite events versus placebo in pooled SELECT, FLOW, and SOUL participants (N=30 787; HR 0·84, 95% CI 0·77–0·91).
Newest first · last 60 days
AI summary · may contain errors
GPR18 signaling in pancreatic islet macrophages is linked to a CD36-dependent Gq/AMPK pathway that remodels sphingolipid metabolism and reduces insulin secretion from β cells.
AI summary · may contain errors
Once-weekly subcutaneous ribupatide in adults in China with overweight or obesity without diabetes produced greater week-48 weight loss than placebo, reaching -17.7% with 6 mg.
AI summary · may contain errors
Continuous glucose monitoring–derived metrics can distinguish conventionally defined prediabetes from normoglycaemia and stratify future glycaemic risk, but immediate diagnostic cut-offs are not established.
AI summary · may contain errors
Smart insulin pens with an integrated bolus calculator improved HbA1c more than tracking-only connected insulin pens over 12 weeks in adults with type 1 or type 2 diabetes on MDI.
AI summary · may contain errors
In adults with overweight or obesity without diabetes in REDEFINE 9, once-weekly cagrilintide-semaglutide 1·7 mg each and 1·0 mg each reduced bodyweight by about 20% at week 68 versus about 2% with placebo.
AI summary · may contain errors
Empagliflozin and dapagliflozin did not stimulate purified recombinant human PANK1 activity in either basal or acetyl-CoA feedback conditions, unlike PZ-2891.
AI summary · may contain errors
In patients with stage 5 chronic kidney disease, SGLT2 inhibitor use is linked to fewer heart failure hospitalizations (HR 0.78; 95% CI 0.72–0.85).
AI summary · may contain errors
A mathematical model jointly describing mouse appetite-driven meal intake across diets and GLP-1RA treatments (semaglutide, exenatide) passed qualitative checks and a chi2 test with disagreement below threshold (348<1111).
AI summary · may contain errors
In aged C57BL/6J mice, semaglutide causes dose-dependent skeletal muscle mass loss in females, including a 14.2% quadriceps reduction at 30 nmol/kg.
AI summary · may contain errors
Intensive systolic blood pressure control to <120 mm Hg versus <140 mm Hg in adults with type 2 diabetes showed no statistically significant difference in all-cause dementia or mild cognitive impairment over a median 3.8 years (HR 0.96, P=0.38).
AI summary · may contain errors
Teplizumab’s 2026 U.S. approval for children and adolescents aged 8–17 with new-onset stage 3 type 1 diabetes reshapes the first weeks after diagnosis.
AI summary · may contain errors
Sodium-glucose cotransporter 2 inhibitors slow chronic kidney disease progression, and a unifying framework links this to metabolic unloading of proximal tubule energetics beyond glycemic and hemodynamic effects.
AI summary · may contain errors
Oral semaglutide in high-risk type 2 diabetes reduced total first-plus-subsequent 3-point MACE versus placebo (mean ratio 0.86; 95% CI 0.76–0.97).
AI summary · may contain errors
Rare damaging GLP1R variants in 13,725 GLP-1RA–treated adults are linked to less weight loss with semaglutide, while tirzepatide weight loss remains near-normal in carriers.
AI summary · may contain errors
Adding thrice-weekly resistance exercise to tirzepatide in 120 adults with overweight or obesity attenuated total lean soft tissue loss by 1.09 kg over 40 weeks.
AI summary · may contain errors
Once-weekly retatrutide improved WOMAC knee pain more than placebo in adults with painful knee osteoarthritis and obesity, with differences up to -1.83 at 68 weeks.
AI summary · may contain errors
Semaglutide 2.4 mg weekly reduced invasively measured pulmonary artery wedge pressure during exercise by -9.8 mmHg versus +0.9 mmHg with placebo in 81 HFpEF patients with obesity.
AI summary · may contain errors
Targeting systolic blood pressure <120 mm Hg versus <140 mm Hg in 9476 patients with type 2 diabetes did not reduce major cardiovascular events over 4.0 years.
AI summary · may contain errors
GLP-1 receptor agonists are linked to thyroid C-cell hyperplasia and neoplasia in dose-dependent rodent studies, but primate and human data do not show C-cell stimulation.
AI summary · may contain errors
In adults with obesity, once-weekly retatrutide produced greater weight loss than placebo over 80 weeks, reaching -25.0% with 12 mg versus -3.9%.
AI summary · may contain errors
REDDIE shows that, when real-world data are carefully aligned with study design and analysis, observational diabetes studies can replicate major randomized trial findings and extend them to broader populations.
Journals this month
Topics moving, week to 17 Nov 2026
By field